Intrinsic Value
Rigel Pharmaceuticals, Inc. (RIGL)
$1.125
-0.01 (-1.32%)
| Enterprise Value | -1,808.51 |
|---|---|
| Net Debt | 27.79 |
| Equity Value | -1,836.31 |
| Shares Outstanding | 174.02 |
| Equity Value Per Share | -10.55 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt